Metropolitan Life Insurance Company (MetLife)’s Northrop Grumman NOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,688
| Closed | -$2.72M | – | 1388 |
|
|
2024
Q1 | $2.72M | Sell |
5,688
-82
| -1% | -$37.8K | 0.12% | 153 |
|
|
2023
Q4 | $2.7M | Sell |
5,770
-114
| -2% | -$53.4K | 0.13% | 138 |
|
|
2023
Q3 | $2.59M | Sell |
5,884
-337
| -5% | -$148K | 0.13% | 134 |
|
|
2023
Q2 | $2.84M | Sell |
6,221
-214
| -3% | -$97.1K | 0.14% | 130 |
|
|
2023
Q1 | $2.97M | Sell |
6,435
-1,689
| -21% | -$784K | 0.15% | 124 |
|
|
2022
Q4 | $4.43M | Sell |
8,124
-536
| -6% | -$280K | 0.2% | 105 |
|
|
2022
Q3 | $4.07M | Sell |
8,660
-143
| -2% | -$68.1K | 0.19% | 104 |
|
|
2022
Q2 | $4.21M | Sell |
8,803
-253
| -3% | -$116K | 0.18% | 112 |
|
|
2022
Q1 | $4.05M | Sell |
9,056
-8,577
| -49% | -$3.54M | 0.14% | 135 |
|
|
2021
Q4 | $6.83M | Sell |
17,633
-700
| -4% | -$261K | 0.09% | 172 |
|
|
2021
Q3 | $6.6M | Sell |
18,333
-539
| -3% | -$195K | 0.1% | 165 |
|
|
2021
Q2 | $6.86M | Sell |
18,872
-7,848
| -29% | -$2.83M | 0.1% | 165 |
|
|
2021
Q1 | $8.65M | Sell |
26,720
-1,527
| -5% | -$460K | 0.13% | 137 |
|
|
2020
Q4 | $8.61M | Sell |
28,247
-720
| -2% | -$220K | 0.13% | 131 |
|
|
2020
Q3 | $9.14M | Sell |
28,967
-1,181
| -4% | -$385K | 0.15% | 113 |
|
|
2020
Q2 | $9.27M | Sell |
30,148
-288
| -0.9% | -$94.4K | 0.16% | 108 |
|
|
2020
Q1 | $9.21M | Sell |
30,436
-581
| -2% | -$202K | 0.19% | 100 |
|
|
2019
Q4 | $10.7M | Sell |
31,017
-698
| -2% | -$245K | 0.17% | 106 |
|
|
2019
Q3 | $11.9M | Sell |
31,715
-1,433
| -4% | -$507K | 0.2% | 86 |
|
|
2019
Q2 | $10.7M | Buy |
33,148
+1,354
| +4% | +$404K | 0.18% | 95 |
|
|
2019
Q1 | $8.57M | Sell |
31,794
-1,629
| -5% | -$444K | 0.16% | 113 |
|
|
2018
Q4 | $8.19M | Buy |
33,423
+109
| +0.3% | +$30.1K | 0.16% | 106 |
|
|
2018
Q3 | $10.6M | Sell |
33,314
-801
| -2% | -$244K | 0.18% | 96 |
|
|
2018
Q2 | $10.5M | Buy |
34,115
+285
| +0.8% | +$94.2K | 0.17% | 104 |
|
|
2018
Q1 | $11.8M | Buy |
33,830
+157
| +0.5% | +$52.6K | 0.17% | 89 |
|
|
2017
Q4 | $10.3M | Sell |
33,673
-55,440
| -62% | -$16.7M | 0.14% | 104 |
|
|
2017
Q3 | $25.6M | Sell |
89,113
-1,387
| -2% | -$373K | 0.16% | 108 |
|
|
2017
Q2 | $23.2M | Sell |
90,500
-1,943
| -2% | -$486K | 0.16% | 124 |
|
|
2017
Q1 | $22M | Sell |
92,443
-2,062
| -2% | -$490K | 0.15% | 125 |
|
|
2016
Q4 | $22M | Sell |
94,505
-3,751
| -4% | -$872K | 0.16% | 124 |
|
|
2016
Q3 | $21M | Sell |
98,256
-2,104
| -2% | -$456K | 0.15% | 125 |
|
|
2016
Q2 | $22.3M | Buy |
100,360
+3,440
| +4% | +$724K | 0.17% | 114 |
|
|
2016
Q1 | $19.2M | Sell |
96,920
-2,102
| -2% | -$397K | 0.15% | 130 |
|
|
2015
Q4 | $18.7M | Sell |
99,022
-5,519
| -5% | -$1.01M | 0.14% | 132 |
|
|
2015
Q3 | $17.3M | Sell |
104,541
-5,217
| -5% | -$874K | 0.12% | 154 |
|
|
2015
Q2 | $17.4M | Sell |
109,758
-522
| -0.5% | -$83.6K | 0.12% | 164 |
|
|
2015
Q1 | $17.8M | Sell |
110,280
-3,365
| -3% | -$538K | 0.13% | 158 |
|
|
2014
Q4 | $16.8M | Sell |
113,645
-4,483
| -4% | -$615K | 0.12% | 174 |
|
|
2014
Q3 | $15.6M | Sell |
118,128
-5,102
| -4% | -$644K | 0.11% | 181 |
|
|
2014
Q2 | $14.7M | Sell |
123,230
-7,760
| -6% | -$938K | 0.1% | 202 |
|
|
2014
Q1 | $16.2M | Sell |
130,990
-5,135
| -4% | -$608K | 0.11% | 182 |
|
|
2013
Q4 | $15.6M | Sell |
136,125
-9,544
| -7% | -$1.02M | 0.11% | 183 |
|
|
2013
Q3 | $13.9M | Sell |
145,669
-3,789
| -3% | -$350K | 0.11% | 195 |
|
|
2013
Q2 | $12.4M | Buy |
+149,458
| New | +$11.6M | 0.1% | 209 |
|
Other funds holding NOC
Metropolitan Life Insurance Company (MetLife)'s NOC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Northrop Grumman (NOC) in Q2 2024, closing a stake of 5,688 shares — an estimated $2.72M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in NOC in Q2 2013 and held it in 44 quarters. The position peaked at $25.6M in Q3 2017. 1,508 funds tracked by Wall St. Rank hold NOC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Northrop Grumman position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 5,688 Northrop Grumman shares in Q2 2024, an estimated $2.72M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Northrop Grumman in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Northrop Grumman position peaked at $25.6M in Q3 2017.
- 1,508 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.